Human papillomavirus type 16 in head and neck carcinogenesis

被引:26
作者
Chen, RW [1 ]
Aaltonen, LM
Vaheri, A
机构
[1] Univ Helsinki, Haartman Inst, Dept Virol, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-00014 Helsinki, Finland
关键词
D O I
10.1002/rmv.471
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The aetiology of squamous cell carcinomas of the head and neck (HNSCC) is multifactorial. Oncogenic human papillomaviruses (HPVs), a causative agent in uterine cervical cancer, have also been repeatedly detected in HNSCC, especially in squamous cell carcinomas of tonsils. Approximately half the HPV DNA-positive HNSCC contain detectable E6/E7 transcripts with wild-type p53, reduced pRb and overexpressed p16 in the tumours. HPV-16 is the predominant type and exists in episomal, integrated, or mixed forms. Tonsillar carcinomas have a remarkably higher viral load than carcinomas at other sites of the head and neck region. HPV-16 DNA has also been detected in tumour-free tonsils. Infection by oncogenic HPVs is a necessary but not a sufficient cause of cancers. Studies on the molecular mechanisms underlying HPV-associated carcinogenesis are difficult, because HPV is not easy to propagate in vitro. HPV-immortahsed human tonsillar epithelial cell lines may provide an in vitro model to study co-factors for the HPV-associated tonsillar cancers and to test the effects of anti-viral and anti-tumour agents. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:351 / 363
页数:13
相关论文
共 160 条
[1]  
Andl T, 1998, CANCER RES, V58, P5
[2]   MOLECULAR-BIOLOGY OF HUMAN PAPILLOMAVIRUS INFECTION AND ONCOGENESIS [J].
ANDROPHY, EJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 103 (02) :248-256
[3]   The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors [J].
Antinore, MJ ;
Birrer, MJ ;
Patel, D ;
Nader, L ;
McCance, DJ .
EMBO JOURNAL, 1996, 15 (08) :1950-1960
[4]   Interaction of the HPV E7 proteins with the pCAF acetyltransferase [J].
Avvakumov, N ;
Torchia, J ;
Mymryk, JS .
ONCOGENE, 2003, 22 (25) :3833-3841
[5]  
Badaracco G, 2000, ANTICANCER RES, V20, P1301
[6]   ADENOVIRUS E1A PROTEINS CAN DISSOCIATE HETEROMERIC COMPLEXES INVOLVING THE E2F TRANSCRIPTION FACTOR - A NOVEL MECHANISM FOR E1A TRANSACTIVATION [J].
BAGCHI, S ;
RAYCHAUDHURI, P ;
NEVINS, JR .
CELL, 1990, 62 (04) :659-669
[7]   STRUCTURAL AND TRANSCRIPTIONAL ANALYSIS OF HUMAN PAPILLOMAVIRUS TYPE-16 SEQUENCES IN CERVICAL-CARCINOMA CELL-LINES [J].
BAKER, CC ;
PHELPS, WC ;
LINDGREN, V ;
BRAUN, MJ ;
GONDA, MA ;
HOWLEY, PM .
JOURNAL OF VIROLOGY, 1987, 61 (04) :962-971
[8]  
Balz V, 2003, CANCER RES, V63, P1188
[9]   ENHANCED DEGRADATION OF P53 PROTEIN IN HPV-6 AND BPV-1 E6-IMMORTALIZED HUMAN MAMMARY EPITHELIAL-CELLS [J].
BAND, V ;
DALAL, S ;
DELMOLINO, L ;
ANDROPHY, EJ .
EMBO JOURNAL, 1993, 12 (05) :1847-1852
[10]   LOSS OF P53 PROTEIN IN HUMAN PAPILLOMAVIRUS TYPE-16 E6-IMMORTALIZED HUMAN MAMMARY EPITHELIAL-CELLS [J].
BAND, V ;
DECAPRIO, JA ;
DELMOLINO, L ;
KULESA, V ;
SAGER, R .
JOURNAL OF VIROLOGY, 1991, 65 (12) :6671-6676